Psychedelic substances have been demonstrated to interact with a variety of neurotransmitter pathways, including those involving serotonin, acetylcholine, norepinephrine, and dopamine. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of psychedelic substances. Further, experts believe that psychedelics, at appropriate doses, can be used to address some of the serious psychological implications associated with the COVID-19 pandemic. 

To order this 250+ page report, which features 120+ figures and 135+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html

The over USD 6.5 billion (by 2030) financial opportunity within the psychedelic therapeutics market has been analyzed across the following segments:

• Target Disease Indication

• Anxiety and Depression
• Trauma
• Pain Disorder
• Sleep related Disorder

• Origin of Psychedelic Substance

• Natural
• Synthetic

• Type of Psychedelic Substance

• Gamma-hydroxybutyrate
• Ketamine
• MDMA
• Psilocybin

• Route of Administration

• Oral
• Intranasal
• Sublingual

• Key Geographies

• North America
• Europe
• Asia-Pacific

The Global Psychedelic Therapeutics Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

• Celon Pharma
• iX Biopharma
• MAPS Public Benefit
• MindMed
• Janssen Pharmaceuticals
• Jazz Pharmaceutical

To request for sample - https://www.rootsanalysis.com/reports/318/request-sample.html

Table of Contents

1. Preface
   
   2. Executive Summary
2. 
   Introduction
   
3. Market Landscape: Psychedelic Therapeutics
   
4. Company Profiles
   
5. Clinical Trial Analysis
   
6. Clinical Trial Site Analysis
   
7. Key Opinion Leader (KOL) Analysis

8. Academic Grants Analysis
   
9. Partnerships and Collaborations
   
10. Mergers and Acquisitions
    
11. Market Forecast and Opportunity Analysis
    
12. Concluding Remarks
    
13. Executive Insights

15. Appendix 1: Tabulated Data

16. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html

You may also be interested in the following titles:

1. In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules, 2020-2030
2. AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030
3. Bioavailability Enhancement Technologies and Services Market, 2020-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis